Found: 35
Select item for more details and to access through your institution.
Heart failure after treatment for breast cancer: old cancer therapies, new clinical data. What do we need to complete the puzzle?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 10, p. 2213, doi. 10.1002/ejhf.3395
- By:
- Publication type:
- Article
Role of real-time three-dimensional transoesophageal echocardiography for guiding transcatheter patent foramen ovale closure.
- Published in:
- European Journal of Echocardiography, 2009, v. 10, n. 1, p. 148, doi. 10.1093/ejechocard/jen214
- By:
- Publication type:
- Article
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 11, p. 3073, doi. 10.1007/s12094-023-03217-2
- By:
- Publication type:
- Article
Cancer and acute cardiovascular diseases: team work to transformthe clinical practice.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, v. 10, n. 8, p. 840, doi. 10.1093/ehjacc/zuab079
- By:
- Publication type:
- Article
Education in cardio-oncology: the next frontiers.
- Published in:
- European Heart Journal, 2024, v. 45, n. 27, p. 2352, doi. 10.1093/eurheartj/ehad895
- By:
- Publication type:
- Article
The year in cardiovascular medicine 2023: the top 10 papers in cardio-oncology.
- Published in:
- European Heart Journal, 2024, v. 45, n. 25, p. 2197, doi. 10.1093/eurheartj/ehae194
- By:
- Publication type:
- Article
Ischaemic heart disease in patients with cancer.
- Published in:
- European Heart Journal, 2024, v. 45, n. 14, p. 1209, doi. 10.1093/eurheartj/ehae047
- By:
- Publication type:
- Article
Harmonizing the cardiovascular care of adult patients with cancer.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 3019, doi. 10.1093/eurheartj/ehad267
- By:
- Publication type:
- Article
'Ten Commandments' for the 2022 European Society of Cardiology guidelines on cardio-oncology.
- Published in:
- European Heart Journal, 2023, v. 44, n. 1, p. 10, doi. 10.1093/eurheartj/ehac666
- By:
- Publication type:
- Article
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4229, doi. 10.1093/eurheartj/ehac244
- By:
- Publication type:
- Article
year in cardiovascular medicine 2021: cardio-oncology.
- Published in:
- European Heart Journal, 2022, v. 43, n. 9, p. 857, doi. 10.1093/eurheartj/ehab891
- By:
- Publication type:
- Article
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
- Published in:
- European Heart Journal, 2022, v. 43, n. 4, p. 280, doi. 10.1093/eurheartj/ehab674
- By:
- Publication type:
- Article
Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council.
- Published in:
- European Heart Journal, 2019, v. 40, n. 22, p. 1756, doi. 10.1093/eurheartj/ehy453
- By:
- Publication type:
- Article
Sustained Improvement of Left Ventricular Strain following Transcatheter Aortic Valve Replacement.
- Published in:
- Cardiology, 2019, v. 143, n. 1, p. 52, doi. 10.1159/000500633
- By:
- Publication type:
- Article
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging.
- Published in:
- NPJ Aging, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41514-024-00135-7
- By:
- Publication type:
- Article
Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1712, doi. 10.3390/cancers13071712
- By:
- Publication type:
- Article
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
European Society of Cardiology Core Curriculum for cardio‐oncology.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 754, doi. 10.1002/ejhf.3102
- By:
- Publication type:
- Article
The cancer patient and cardiology.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 12, p. 2290, doi. 10.1002/ejhf.1985
- By:
- Publication type:
- Article
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC)
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1504, doi. 10.1002/ejhf.1957
- By:
- Publication type:
- Article
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 6, p. 859, doi. 10.1093/eurjpc/zwaa034
- By:
- Publication type:
- Article
Cardio-oncology: a new field requiring guidance.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 3, p. e47, doi. 10.1093/ehjci/jeac250
- By:
- Publication type:
- Article
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2022, v. 23, n. 10, p. e333, doi. 10.1093/ehjci/jeac106
- By:
- Publication type:
- Article
Immediate improvement of left ventricular mechanics following transcatheter aortic valve replacement.
- Published in:
- Cardiology Journal, 2018, v. 25, n. 4, p. 487, doi. 10.5603/CJ.a2018.0066
- By:
- Publication type:
- Article
Effectiveness of sacubitril–valsartan in cancer patients with heart failure.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 2, p. 763, doi. 10.1002/ehf2.12627
- By:
- Publication type:
- Article
Modern‐day cardio‐oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1083, doi. 10.1002/ehf2.12386
- By:
- Publication type:
- Article
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 8, p. 553, doi. 10.1007/s40261-024-01379-7
- By:
- Publication type:
- Article
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2019, v. 20, n. 5, p. 582, doi. 10.1093/ehjci/jey188
- By:
- Publication type:
- Article
Cardiac monitoring during trastuzumab therapy in metastatic breast cancer: early incidence of cardiac dysfunction.
- Published in:
- Monaldi Archives for Chest Disease, 2022, v. 92, n. 4, p. 174, doi. 10.4081/monaldi.2022.2163
- By:
- Publication type:
- Article
Focused echocardiography in cardio‐oncology.
- Published in:
- Echocardiography, 2020, v. 37, n. 8, p. 1149, doi. 10.1111/echo.14800
- By:
- Publication type:
- Article
Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial.
- Published in:
- Cardio-Oncology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40959-024-00260-y
- By:
- Publication type:
- Article
Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement.
- Published in:
- CA: A Cancer Journal for Clinicians, 2020, v. 70, n. 6, p. 480, doi. 10.3322/caac.21635
- By:
- Publication type:
- Article